1. Home
  2. RVNC vs MTA Comparison

RVNC vs MTA Comparison

Compare RVNC & MTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVNC
  • MTA
  • Stock Information
  • Founded
  • RVNC 1999
  • MTA 1983
  • Country
  • RVNC United States
  • MTA Canada
  • Employees
  • RVNC N/A
  • MTA N/A
  • Industry
  • RVNC Biotechnology: Pharmaceutical Preparations
  • MTA
  • Sector
  • RVNC Health Care
  • MTA
  • Exchange
  • RVNC Nasdaq
  • MTA Nasdaq
  • Market Cap
  • RVNC 546.4M
  • MTA 237.9M
  • IPO Year
  • RVNC 2014
  • MTA N/A
  • Fundamental
  • Price
  • RVNC $5.29
  • MTA $3.93
  • Analyst Decision
  • RVNC Buy
  • MTA
  • Analyst Count
  • RVNC 10
  • MTA 0
  • Target Price
  • RVNC $10.86
  • MTA N/A
  • AVG Volume (30 Days)
  • RVNC 1.3M
  • MTA 341.7K
  • Earning Date
  • RVNC 11-06-2024
  • MTA 11-08-2024
  • Dividend Yield
  • RVNC N/A
  • MTA 0.58%
  • EPS Growth
  • RVNC N/A
  • MTA N/A
  • EPS
  • RVNC N/A
  • MTA N/A
  • Revenue
  • RVNC $251,178,000.00
  • MTA $4,785,000.00
  • Revenue This Year
  • RVNC $20.36
  • MTA $44.55
  • Revenue Next Year
  • RVNC $31.66
  • MTA $149.35
  • P/E Ratio
  • RVNC N/A
  • MTA N/A
  • Revenue Growth
  • RVNC 40.23
  • MTA 48.42
  • 52 Week Low
  • RVNC $2.30
  • MTA $2.32
  • 52 Week High
  • RVNC $9.75
  • MTA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • RVNC 44.50
  • MTA 74.68
  • Support Level
  • RVNC $5.10
  • MTA $3.53
  • Resistance Level
  • RVNC $5.43
  • MTA $3.68
  • Average True Range (ATR)
  • RVNC 0.17
  • MTA 0.16
  • MACD
  • RVNC 0.02
  • MTA 0.05
  • Stochastic Oscillator
  • RVNC 66.67
  • MTA 89.67

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.

Share on Social Networks: